InflaRx Share Price

InflaRx Share Price

NASDAQ: IFRX | Healthcare
$1.10
-$0.05 (-4.35%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

InflaRx Stock Performance

Open
$1.15
Prev. Close
$1.15
Circuit Range
N/A
Day Range
$1.06 - $1.19
Year Range
$0.80 - $2.94
Volume
1,32,040
Average Traded
$1.10

InflaRx Share Price Today

As of 19 November 2026, InflaRx N.V.'s share price is $1.10. The stock opened at $1.15, compared to its previous close of $1.15. During today's trading session, InflaRx N.V.'s share price traded between $1.06 and $1.19, with an average price of $1.13. Over the past 52 weeks, the stock has recorded a high of $2.94 and a low of $0.80. In terms of performance, InflaRx N.V.'s share price has declined by 54.17% over the last six months and is down 13.04% on a year-on-year basis.

InflaRx Share Price Chart

Line chart of the InflaRx price trend over the selected period. The price fell overall, ranging from 1.07 to 1.19, ending at 1.10.
$1.06$1.19
L
Show Current Price
H

InflaRx Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$30.00M
Return On Equity (TTM)
N/A
Profit Margin
-178466.67%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

InflaRx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.07$0.17$0.03
Net Profit-$31.63-$47.17-$47.93-$53.54
Net Profit MarginN/A-67385.71%-28194.12%-178466.67%
Income ChangeN/A-49.13%-1.61%-11.70%

InflaRx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.864.5411.874.99
Current Assets62.9374.56121.0197.41
Total Assets64.7879.1132.89102.4
Non Current Liabilities0.80.450.871.02
Current Liabilities15.2314.7418.6213.03
Total Liabilities16.0315.1919.4914.05
Shareholders' Equity48.7663.91113.488.35

InflaRx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-41.43-50.53-41.8-36.2
Investing3.7954.49-19.5620.76
Financing39.090.458.572.08

About InflaRx

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

InflaRx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.71
$1.10
-34.13%
Oct 2026
$1.81
$1.67
-7.73%
Sep 2026
$2.13
$1.81
-20.09%
Aug 2026
$1.68
$2.27
+34.02%
Jul 2026
$2.21
$1.69
-24.72%
Jun 2026
$2.40
$2.25
-6.46%
May 2026
$2.03
$2.40
+15.66%
Apr 2026
$0.90
$2.08
+141.56%
Mar 2026
$0.91
$0.86
-6.43%
Feb 2026
$0.91
$0.92
+4.20%
Jan 2026
$1.05
$0.88
-13.63%
Dec 2025
$1.23
$1.02
-19.37%

InflaRx Share Price FAQs